Fueling chemotherapy resistance in triple-negative breast cancer
- Department / Centre
- Biochemistry and Pharmacology
|Dr Kristin Brownfirstname.lastname@example.org|
Summary Deregulated cellular metabolism is a well-established hallmark of cancer. The Brown group uses a range of molecular biology, cell biology and biochemistry techniques to investigate the ways in which deregulated cellular metabolism contributes to cancer initiation, cancer progression and therapy resistance. The knowledge gained from these studies is applied to the pre-clinical development of novel anticancer therapies.